News Release

News Release

25,Apr,2013


This License Agreement, effective as of March 11, 2013, has been made between Peptide Door Co., Ltd., located at 1F City Heights Garnet 794-21 Fukushima, Takasaki, Gunma 370-3523 Japan, and Charles River Laboratories, Inc., located at 1023 Wappoo road, Suite 43B, Charleston, SC 29407, USA.

Peptide Door gave Charles River a license to develop and commercialize the products containing the compound Li5-025, endotoxin binding peptide, and its derivatives for laboratory and diagnostic use for endotoxin detection, endotoxin removal and recovery worldwide.

bHomebNews ReleasebCompanybProductsbTechnologiesbWorking with PDbContact usbLinksbSite mapb